Related Experiment Videos
Experimental asthma in guinea pigs revisited
International Archives of Allergy and Applied Immunology
|January 1, 1984
Summary
Guinea pig asthma, a model for human asthma bronchiale, involves aberrant antibody formation. This leads to mediator release, causing bronchoconstriction and inflammation upon re-exposure to allergens.
Area of Science:
- Immunology
- Pulmonology
- Veterinary Pathology
Background:
- Experimental asthma in guinea pigs, established in 1937, serves as a model for human asthma.
- Asthma bronchiale in humans shares underlying mechanisms with experimental models.
Purpose of the Study:
- To review the literature on experimental asthma in guinea pigs.
- To establish the relationship between guinea pig asthma and human asthma bronchiale.
- To elucidate the immunological mechanisms involved in both conditions.
Main Methods:
- Literature review of experimental asthma models in guinea pigs.
- Comparative analysis of pathological and immunological findings in guinea pig and human asthma.
Main Results:
- The study establishes a strong correlation between experimental guinea pig asthma and human asthma bronchiale.
- The underlying mechanism identified is the aberrant formation of anaphylactic or reaginic (Immunoglobulin E) antibodies.
- Antigen re-exposure triggers the release of mast cell mediators, including histamine, SRS-A, eosinotactic peptides, and PAF.
Conclusions:
- Aberrant Immunoglobulin E antibody production is a key mechanism in both guinea pig and human asthma.
- Mast cell mediator release leads to bronchoconstriction, vasodilation, and eosinophilic inflammation.
- The guinea pig model is relevant for understanding human asthma pathogenesis and developing therapeutic strategies.